BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34252073)

  • 1. Identification and engraftment of new bacterial strains by shotgun metagenomic sequence analysis in patients with recurrent Clostridioides difficile infection before and after fecal microbiota transplantation and in healthy human subjects.
    Verma S; Dutta SK; Firnberg E; Phillips L; Vinayek R; Nair PP
    PLoS One; 2021; 16(7):e0251590. PubMed ID: 34252073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
    Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota restoration therapies for recurrent
    DuPont HL; DuPont AW; Tillotson GS
    Therap Adv Gastroenterol; 2024; 17():17562848241253089. PubMed ID: 38800353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection.
    Millan B; Park H; Hotte N; Mathieu O; Burguiere P; Tompkins TA; Kao D; Madsen KL
    Clin Infect Dis; 2016 Jun; 62(12):1479-1486. PubMed ID: 27025836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.
    Girotra M; Garg S; Anand R; Song Y; Dutta SK
    Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The success of fecal microbial transplantation in
    Park H; Laffin MR; Jovel J; Millan B; Hyun JE; Hotte N; Kao D; Madsen KL
    Gut Microbes; 2019; 10(6):676-687. PubMed ID: 30866714
    [No Abstract]   [Full Text] [Related]  

  • 7. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.
    Song Y; Garg S; Girotra M; Maddox C; von Rosenvinge EC; Dutta A; Dutta S; Fricke WF
    PLoS One; 2013; 8(11):e81330. PubMed ID: 24303043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients.
    Nooij S; Ducarmon QR; Laros JFJ; Zwittink RD; Norman JM; Smits WK; Verspaget HW; Keller JJ; Terveer EM; Kuijper EJ;
    Gastroenterology; 2021 Oct; 161(4):1218-1228.e5. PubMed ID: 34126062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent
    Azimirad M; Jo Y; Kim MS; Jeong M; Shahrokh S; Asadzadeh Aghdaei H; Zali MR; Lee S; Yadegar A; Shin JH
    J Inflamm Res; 2022; 15():105-116. PubMed ID: 35023946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
    Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota.
    Staley C; Vaughn BP; Graiziger CT; Singroy S; Hamilton MJ; Yao D; Chen C; Khoruts A; Sadowsky MJ
    Gut Microbes; 2017 May; 8(3):276-288. PubMed ID: 28282270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metagenomic strain detection with SameStr: identification of a persisting core gut microbiota transferable by fecal transplantation.
    Podlesny D; Arze C; Dörner E; Verma S; Dutta S; Walter J; Fricke WF
    Microbiome; 2022 Mar; 10(1):53. PubMed ID: 35337386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Steed DB; Wang T; Raheja D; Waldman AD; Babiker A; Dhere T; Kraft CS; Woodworth MH
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metagenomic and bile acid metabolomic analysis of fecal microbiota transplantation for recurrent Clostridiodes difficile and/or inflammatory bowel diseases.
    Ramos RJ; Zhu C; Joseph DF; Thaker S; Lacomb JF; Markarian K; Lee HJ; Petrov JC; Monzur F; Buscaglia JM; Chawla A; Small-Harary L; Gathungu G; Morganstern JA; Yang J; Li J; Pamer EG; Robertson CE; Frank DN; Cross JR; Li E
    Med Res Arch; 2022 Oct; 10(10):. PubMed ID: 36618438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent
    Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR
    Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection.
    Staley C; Kaiser T; Vaughn BP; Graiziger C; Hamilton MJ; Kabage AJ; Khoruts A; Sadowsky MJ
    mBio; 2019 Jul; 10(4):. PubMed ID: 31337728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children With Recurrent Clostridium Difficile Infection.
    Li X; Gao X; Hu H; Xiao Y; Li D; Yu G; Yu D; Zhang T; Wang Y
    Front Microbiol; 2018; 9():2622. PubMed ID: 30450088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes.
    Anand R; Song Y; Garg S; Girotra M; Sinha A; Sivaraman A; Phillips L; Dutta SK
    Dig Dis Sci; 2017 Apr; 62(4):1002-1008. PubMed ID: 28181098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent
    Tian H; Cui J; Ye C; Zhao J; Yang B; Xu Y; Ji S; Wang L; Lv X; Ma C; Zhou S; Li N; Wang X; Qin H; Chen Q
    Gut Microbes; 2023; 15(1):2236362. PubMed ID: 37469017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal microbiota transplantation for treatment of patients with recurrent
    Voth E; Khanna S
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.